MASSIRONI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 1.634
EU - Europa 1.350
AS - Asia 749
SA - Sud America 79
AF - Africa 9
OC - Oceania 4
Totale 3.825
Nazione #
US - Stati Uniti d'America 1.613
RU - Federazione Russa 350
IT - Italia 325
SG - Singapore 322
DE - Germania 199
IE - Irlanda 179
HK - Hong Kong 173
CN - Cina 145
SE - Svezia 132
BR - Brasile 72
GB - Regno Unito 35
ID - Indonesia 30
FR - Francia 29
FI - Finlandia 19
AT - Austria 17
UA - Ucraina 16
CA - Canada 15
IN - India 13
NL - Olanda 13
PH - Filippine 12
BE - Belgio 8
KR - Corea 8
PL - Polonia 7
VN - Vietnam 7
CZ - Repubblica Ceca 5
TW - Taiwan 5
AU - Australia 4
MM - Myanmar 4
MX - Messico 4
MY - Malesia 4
TR - Turchia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
EC - Ecuador 3
EG - Egitto 3
PK - Pakistan 3
BG - Bulgaria 2
DK - Danimarca 2
IL - Israele 2
KG - Kirghizistan 2
MA - Marocco 2
SA - Arabia Saudita 2
ZA - Sudafrica 2
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BJ - Benin 1
CO - Colombia 1
DZ - Algeria 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
JP - Giappone 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
TJ - Tagikistan 1
VE - Venezuela 1
Totale 3.825
Città #
Ann Arbor 510
Singapore 253
Dublin 173
Hong Kong 173
Frankfurt am Main 146
Chandler 118
Milan 106
Ashburn 71
Fairfield 67
Wilmington 62
Santa Clara 54
New York 53
Shanghai 51
Moscow 42
Princeton 41
Houston 33
Woodbridge 32
Jakarta 29
Los Angeles 27
Chicago 25
Seattle 24
London 23
Cambridge 22
Beijing 21
Hefei 21
Lawrence 20
Florence 19
Altamura 17
San Diego 17
Hangzhou 14
Rome 14
Nuremberg 13
Bari 11
Helsinki 11
Guangzhou 10
Munich 10
Davao City 8
Boardman 7
Desio 7
Garbagnate Milanese 7
Seo-gu 7
São Paulo 7
Toronto 7
Vienna 7
Falls Church 6
Pune 6
Brno 5
Comazzo 5
Dearborn 5
Dong Ket 5
Düsseldorf 5
Romola 5
Andover 4
Antwerp 4
Bologna 4
Butuan 4
Fremont 4
Genoa 4
Jinan 4
Monza 4
Rio de Janeiro 4
Tashkent 4
Turku 4
Wroclaw 4
Antibes 3
Belo Horizonte 3
Bergamo 3
Brussels 3
Cinisello Balsamo 3
Council Bluffs 3
Hyderabad 3
Jacksonville 3
Kilburn 3
Kuala Lumpur 3
Lappeenranta 3
Lauterbourg 3
Modena 3
Naples 3
New Taipei 3
Roubaix 3
Sydney 3
Vicenza 3
Vigevano 3
Warsaw 3
Arese 2
Atlanta 2
Bellinzago Novarese 2
Bonndorf 2
Brasília 2
Brooklyn 2
Bushey 2
Cairo 2
Casatenovo 2
Changsha 2
Charlotte 2
Dallas 2
Dubai 2
Esslingen am Neckar 2
Federal Way 2
Groningen 2
Totale 2.572
Nome #
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma 222
DCLK1, a putative novel stem cell marker in human cholangiocarcinoma 218
The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective 215
Understanding short bowel syndrome: Current status and future perspectives 205
Endoscopic Findings in Patients Infected With 2019 Novel Coronavirus in Lombardy, Italy 196
High rates of 30-day mortality in patients with cirrhosis and COVID-19 187
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 177
Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study 155
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 147
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 147
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 104
Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study 99
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 98
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 97
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies 88
Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management 81
Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review 78
Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis 77
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 77
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future 77
Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms 74
Clinical challenge for gastroenterologists–Gastrointestinal manifestations of systemic mastocytosis: A comprehensive review 73
Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO) 71
Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? 70
Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy 70
Exploring the spectrum of incidental gastric polyps in autoimmune gastritis 67
Eosinophilic esophagitis: does age matter? 65
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 64
Use of IBD Drugs in Patients with Hepatobiliary Comorbidities: Tips and Tricks 61
COVID-19 in patients with neuroendocrine neoplasms: two-year results of the INTENSIVE study 60
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 56
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 55
Impact of metformin on the incidence of human cholangiocarcinoma in diabetic patients: A systematic review and meta-analysis 54
Paradoxical association between dyspepsia and autoimmune chronic atrophic gastritis: Insights into mechanisms, pathophysiology, and treatment options 54
Sporadic and MEN1-related gastrinoma and Zollinger–Ellison syndrome: differences in clinical characteristics and survival outcomes 53
Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? 49
Systematic review-Pancreatic involvement in inflammatory bowel disease 47
Ultrasound muscle assessment for sarcopenia detection in inflammatory bowel disease: A prospective study 47
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: Interim analysis of prospective ASPEN trial 45
Long-term albumin improves the outcomes of patients with decompensated cirrhosis and diabetes mellitus: Post hoc analysis of the ANSWER trial 43
Beyond the gluten-free diet: Innovations in celiac disease therapeutics 41
Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance 39
Totale 4.003
Categoria #
all - tutte 20.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202019 0 0 0 0 0 0 0 0 0 0 14 5
2020/2021568 26 8 45 34 67 70 63 70 47 47 44 47
2021/2022411 38 43 55 28 41 28 3 22 28 24 22 79
2022/2023594 65 148 54 57 59 63 19 34 42 12 19 22
2023/2024673 18 11 17 85 62 151 120 33 58 17 13 88
2024/20251.622 90 164 157 77 148 99 137 57 152 334 207 0
Totale 4.003